The dermal papilla (DP) plays pivotal roles in hair follicle morphogenesis and cycling. 2 However, characterization and/or propagation of human DP have been unsatisfactory 3 because of the lack of efficient isolation methods and the loss of innate characteristics in 4 vitro. We hypothesized that culture conditions sustaining the intrinsic molecular 5 signature of human DP could facilitate expansion of functional DP cells. To test this, we 6 first characterized the global gene expression profile of microdissected, non-cultured 7 human DPs. We performed a "two-step" microarray analysis to exclude the influence of 8 unwanted contaminants in isolated DPs and successfully identified 118 human DP 9 signature genes, including 38 genes listed in the mouse DP signature. The 10 bioinformatics analysis of the DP gene list revealed that WNT, BMP and FGF signaling 11 pathways were upregulated in intact DP and addition of 6-bromoindirubin-3'-oxime, 12 recombinant BMP2 and basic FGF to stimulate these respective signaling pathways 13 resulted in maintained expression of in situ DP signature genes in primarily cultured 14 human DP cells. More importantly, the exposure to these stimulants restored normally 15 reduced DP biomarker expression in conventionally cultured DP cells. Cell growth was 16 moderate in the newly developed culture condition. However, rapid DP cell expansion 17 by conventional culture followed by the restoration by defined activators provided a 18 sufficient number of DP cells, which demonstrated characteristic DP activities in 19 functional assays. The present study revealed previously unreported molecular 20 mechanisms contributing to human DP properties and describes a useful technique for 21 the investigation of human DP biology and hair follicle bioengineering. 22 23
Introduction 1
The dermal papilla (DP) is a highly specialized mesenchymal component located at the 2 base of hair follicles (Paus and Cotsarelis, 1999; Stenn and Paus, 2001; Driskell et al., 3 2011) . Previous studies, including hair reconstitution experiments, have demonstrated 4 the indispensable roles of DP in epithelial-mesenchymal interactions that enable hair 5 follicle morphogenesis and cycling (for reviews see Oliver, 1991; Jahoda and Reynolds, 6 1996; Millar, 2002; Botchkarev and Kishimoto, 2003; Ohyama et al., 2010; Yang and 7 Cotsarelis, 2010; Driskell et al., 2011) . In mice, elegant transgenic approaches 8 (Kishimoto et al., 1999; Rendl et al., 2005; Driskell et al., 2009 ) and newly identified 9 cell surface markers such as CD133 (Ito et al., 2007) and α9-integrin (Rendl et al., 10 2008) enabled fluorescent labeling and targeted isolation of living DP cells. Sufficient 11 numbers of mouse DP cells are now available for downstream applications such as 12 microarray analysis and tissue regeneration assays (Rendl et al., 2005; Rendl et al., 13 2008; Driskell et al., 2009 ). However, isolation of human DP cells mostly depends on 14 manual microdissection, which provides a limited number of DP cells (Messenger, 15 1984; Magerl et al., 2002; Ohyama et al., 2010) . Accordingly, previous studies of 16 human DP predominantly utilized cultured DP cells (Inui et al., 2003; Pflieger et al., 17 2006; Iino et al., 2007; Park et al., 2007; Shin et al., 2010) . A potential disadvantage of 18 this approach is the loss of some intrinsic properties of DP cells during culture (Ohyama 19 et al., 2010; Yang and Cotsarelis, 2010) . Loss of biological characteristics, especially 20 hair inductive capacity, has been reported in rodent (Jahoda et al., 1984; Horne et al., 21 between DP and the hair matrix (Fig. 2B ). These findings indicate that a fundamental 23 molecular mechanism is conserved between mouse and human DP cells. 24 25
Development of DP activation culture condition (DPAC): optimized culture 26 condition that maintains the intrinsic properties of human DP cells 27
As an application of the results obtained above, we attempted to develop a culture 28 condition that allows human DP cell expansion while sustaining intrinsic properties, 29 including the molecular signature. Because the bioinformatics analysis implied the 30 involvement of WNT, BMP, and FGF signaling pathways in the maintenance of humanDP properties, we anticipated that stimulation of these pathways during culture would 1 improve the biological characteristics of cultured DP cells. To test this hypothesis, 2 6-bromoindirubin-3'-oxime (BIO), recombinant BMP2 (rBMP), and basic FGF (bFGF) 3
were individually added to conventionally used 10% FBS-DMEM to stimulate the 4 WNT, BMP, and FGF pathways, respectively. 5
To assess the effect of each activator on DP properties, expression of the classic DP 6 genes ALPL, lymphoid enhancer-binding factor 1 (LEF1), and NOG, as well as of RGS2, 7 a DP gene identified in this study, was monitored (Fig. 3A) . Interestingly, the 8 expression of these genes was not always upregulated in a dose-dependent manner (Fig. 9 3A) . BIO markedly increased the expression of all tested genes at concentrations of 1 10 μM and higher. However, cell proliferation was markedly suppressed in 2 μM BIO. The 11 ameliorative effect of rBMP on DP gene expression did not differ significantly between 12 200 or 400 ng/ml. bFGF dose-dependently enhanced DP cell proliferation. However, an 13 increase in dead cells, probably due to overproliferation, was observed at 40 ng/ml (data 14 not shown). Although downregulation of ALPL was observed at a higher concentration, 15 upregulation of other genes was maintained at 20 ng/ml. Accordingly, each activator 16 differently maintained DP signature gene expression at an individual optimal 17 concentration of 1 μM for BIO, 200 ng/ml for rBMP, and 20 ng/ml for bFGF (Fig. 3A) . 18
We next prepared 10% FBS-DMEM containing optimal concentrations of two or 19 all three factors and cultured fDP cells. The combination of rBMP and bFGF enhanced 20 DP cell proliferation, whereas the mixture of BIO and bFGF or all three factors reduced 21 DP cell growth to approximately 30% that of controls (Fig. 3B ). In addition, DP cells 22 hardly proliferated when exposed to the combination of BIO and rBMP (data not 23 shown). Importantly, the combination of all three factors caused statistically significant 24 (p < 0.05) upregulation of all tested DP signature genes compared with controls ( Fig.  25   3C) . Thus, 10% FBS-DMEM containing 1 μM BIO, 200 ng/ml rBMP, and 20ng/ml 26 bFGF provided the most favorable conditions for maintaining proliferative capacity and 27 intrinsic gene expression in cultured human DP cells. We named this condition "dermal 28 papilla activation culture condition" or DPAC. 29
Expression of other classic DP signature genes in DP cells primarily cultured inpentraxin 3 (PTX3), a Fibro signature gene upregulated in cDP compared with fDP, was 1 significantly underrepresented in dpacDP vs. cDP, further confirming the effect of 2 DPAC (Fig. 3D) . 3
Both the conventional condition (10% FBS-DMEM) and DPAC allowed DP cell 4 expansion for more than five passages (Fig. 3E) . Early-passage dpacDP cells 5 predominantly demonstrated a small polygonal appearance distinct from the 6 fibroblast-like morphology of cDP cells. However, numbers of spindle-shaped cells 7 increased in higher-passage dpacDP (Fig. 3E) . Consistent with this observation, ALPL, 8 NOG, and BMP4 gene expression and alkaline phosphatase enzyme (ALP) activity, 9 which correlates with the hair inductive capacity of DP cells (McElwee et al., 2003; 10 Rendl et al., 2008) , were maintained in early-passage dpacDP at levels comparable with 11 those in fDP (Fig. 3F, G) . Thus, the effects of DPAC persisted for several passages. 12 13 DPAC sustained the intrinsic molecular signature of intact human DP 14
Human DP cells primarily cultured in DPAC sustained the expression of previously 15 undescribed human DP signature genes (Fig. 4) . LRP4, which is reportedly a specific 16 marker of murine DP (Lrp4/corin) (Enshell-Seijffers et al., 2008; Enshell-Seijffers et al., 17 2010) , was almost identically expressed in fDP and dpacDP (Fig. 4) . Likewise, BMP 18 and activin membrane-bound inhibitor homolog (BAMBI) and SPRY4, antagonists of 19 TGF-β and FGF pathways (Furthauer et al., 2001; Sekiya et al., 2004) , respectively, and 20 NDP, an activator of WNT signaling (Seitz et al., 2010) , were similarly expressed in 21 fDP and dpacDP cells (Fig. 4) . Expression of those not directly related to the activated 22 pathways, including ETV1; GPR125; guanylate cyclase 1, soluble, alpha 3 (GUCY1A3); 23 and semaphorin-4C (SEMA4C), were also well maintained (Fig. 4) . 24
Trichorhinophalangeal syndrome I (TRPS1), a gene responsible for human congenital 25 hair anomalies (Momeni et al., 2000) , and sex-determining region Y-box 2 (SOX2), a 26 mouse DP gene that defines a hair shaft phenotype (Driskell et al., 2009) , were highly 27 expressed in dpacDP compared with cDP cells (Fig. 4) . These findings indicate that 28 DPAC provides a useful tool to probe the links between potential DP signature genes 29 and human DP biology. 30
Restoration of impaired DP properties in conventionally cultured human DP cells 1
by DPAC 2
When DP cells initially cultured in 10% FBS-DMEM were passaged into DPAC 3 (yielding dpacDP P1 cells; Fig. 5A ), their morphology changed from spindle-shaped to 4 a polygonal form resembling that of DP cells primarily cultured in DPAC (Fig. 5B) . In 5 line with this observation, DP signature genes such as ALPL, LEF1, and NOG were 6 upregulated after passaging into DPAC (Fig. 5C ). In addition, ALP activity was much 7 higher in dpacDP P1 cells compared with passage-one cDP cells (cDP P1 cells; Fig. 5A , 8 D). Thus, DPAC ameliorated DP biomarker expression reduced in conventionally 9 cultured DP cells. 10
To assess whether exposure to DPAC improved DP functions, either dpacDP P1 or 11 cDP P1 cells were co-cultured with normal human hair follicle keratinocytes (Fig. 6A ) 12 (Inui et al., 2002) . In the bulb of the hair follicle, DP cells interact with hair matrix cells, 13 actively dividing keratinocytes that generate the hair shaft (Rendl et al., 2005 (Rendl et al., , 2008 14 Ohyama et al., 2010) . Intriguingly, dpacDP P1 cells significantly increased the 15 expression of hair matrix signature genes LEF1 and msh homeobox 2 (MSX2) (Rendl et 16 al., 2005) in keratinocytes compared with cDP P1 cells, suggesting that exposure to 17 DPAC ameliorated the capacity of DP cells to provoke epithelial-mesenchymal 18 interactions in the hair follicle (Fig. 6B) . 19
An in vivo hair induction assay was subsequently performed. DP-like cell 20 aggregates were generated from dpacDP P1 or cDP P1 cells and placed between 21 enzymatically separated afollicular murine sole epidermis and dermis. The "sandwich" 22 composites were then inserted subcutaneously into immunodeficient mice (Fig. 6C) . 23
Intriguingly, developments suggestive of hair morphogenesis, including epidermal 24 invagination or papillary mesenchymal body formation (Osada and Kobayashi, 2000; 25 Osada et al., 2009) (Fig. 6D) , were observed in 9 of 21 mice in the DPAC-treated group, 26 but only in 2 of 18 mice in the control group (p < 0.05). These developments were 27 surrounded by dermal cells positive for ALP and human-specific vimentin staining (Fig.  28 6D, E), suggesting that they were induced by transplanted human DP cells. 29
These findings demonstrate that DPAC restores some aspects of DP cell function in 30 conventionally cultured DP cells.
Discussion 1
The success of microarray analysis greatly depends on the purity of the tested cell 2 populations (Rendl et al., 2005) . Microdissected DP predominantly comprised DP cells, 3 as demonstrated by high expression of established DP signature genes. However, the 4 vascular structure within DP could not be removed, and complete detachment of the 5 surrounding hair matrix cells and melanocytes was hardly achieved by the 6 microdissection technique (Ohyama et al., 2010; Kobayashi et al., 2011) . Because the 7 isolation of a pure DP cell population is currently not feasible in humans (Ohyama et al., 8 2010) , a methodology that allows for the exclusion of non-DP-related genes from fDP 9 upregulated genes must be developed to obtain a bona fide intact DP gene expression 10
profile. 11
We previously successfully identified the markers of human hair follicle putative 12 stem cells by "two-step" microarray analyses (Ohyama et al., 2006) . We adopted this 13 approach to filter out unwanted genes. Because no signal from possible contaminants 14 was detected on cDP, Fibro, or agDP arrays, comparisons between cDP and Fibro 15
GeneChips and agDP and cDP GeneChips should detect the differential expression of 16 the genes expressed in DP cells. These preceding microarray analyses provided the 17 criteria with which to link a gene to DP fate in each subsequent step. In Approach 1, the 18 second step could be crucial because some DP signature genes might be detected as 19 downregulated in fDP compared with cDP cells and discarded due to the lower 20 occupancy of DP cells in fDP subsets. However, previously reported DP genes 21 (Botchkarev and Kishimoto, 2003; Rendl et al., 2005; Ito et al., 2007; Osada et al., 22 2007; Driskell et al., 2009; Ohyama et al., 2010) were not among the genes excluded in 23 this step, suggesting that this loss is unlikely. 24
Theoretically, Approach 1 could not detect any DP gene downregulated in cDP 25 cells to a level similar to that in Fibros. In truth, cDP cells exhibited a global gene 26 expression pattern resembling that of Fibros (Fig. 1G) , indicating the need for additional 27 analyses. Although Approach 2 identified as many as 77 DP signature genes, excluding 28 those expressed in contaminants in microdissected DP, some DP signature genes likely 29 remained undetected because of the limitation intrinsic to this approach that not all DP 30 signature genes were upregulated by cell aggregation. Indeed, 12 established DP genes (Botchkarev and Kishimoto, 2003; Rendl et al., 2005; Ito et al., 2007; Osada et al., 1 2007; Driskell et al., 2009; Ohyama et al., 2010) were upregulated in fDP compared 2 with cDP cells and Fibros, but were not detected by Approach 2. Importantly, half of 3 those genes were selected by another analysis and finally listed as DP signature genes. 4
This result, together with the observation that only four genes were common to both 5 analyses, suggests that the combination of individual approaches was beneficial. 6
The current study identified 118 human DP signature genes, whereas global gene 7 expression profiling of FACS-sorted pure mouse DP cells returned 225 DP signature 8 genes (Rendl et al., 2005) , most of which overlapped with the genes recently identified 9 in CD133+ mouse DP cells (Driskell et al., 2009 ). Thus, a considerable number of 10 human DP signature genes were not detected in the present study. Our two-step criteria 11
were sufficiently stringent to identify selective markers, but may have been too 12 restrictive to fully unveil the molecular signature of tested populations. Successful For the development of DPAC, we adopted BIO, rBMP, and basic FGF to stimulate 7 biological pathways downregulated during conventional culture. BIO is a small 8 molecule commonly used to activate canonical WNT signaling in cultured cells (Sato et 9 al., 2004; Yamauchi and Kurosaka, 2009) . Although BMP6 improved mouse DP cell 10 properties more efficiently than BMP2/BMP4 (Rendl et al., 2008), we did not detect 11 upregulation of BMP6 in human fDP. Based on the observations that BMP2 was 12 markedly suppressed during conventional culture and upregulated during DP cell 13 aggregation, we selected this molecule as a BMP signaling activator. bFGF upregulated 14 some DP signature genes, suggesting that active FGF signaling contributes not only to 15 cell proliferation, but also to the maintenance of DP properties. As suggested by 16 decreased expression of NOG, SOX2, and TRPS1 in dpacDP compared with that in fDP 17 cells, dpacDP cells probably did not perfectly reproduce the molecular signature of in 18 situ DP. Once a pure human DP cell population is isolated, microarray comparison 19 between intact DP and dpacDP cells must be performed to more precisely assess the 20 ability of DPAC to sustain DP properties. The findings obtained by this analysis could 21 enable further improvement of DPAC. 22
In previous studies, supplementation of exogenous Wnt or Bmp molecules 23 maintained mouse DP cell properties in culture, but did not affect their proliferative 24 capacities (Rendl et al., 2008) . For clinical application, the use of BIO may be 25 advantageous because Wnt is not widely available in large quantities and may exhibit 26 unwanted effects via non-canonical pathways (Shimizu and Morgan, 2004) . However, 27
considering that DP growth suppression due to BIO (Yamauchi and Kurosaka, 2009) 28 represents a major drawback of DPAC, BIO may be substituted by recombinant 29 WNT3A (Kishimoto et al., 2000; Shimizu and Morgan, 2004) to maintain the intrinsic 30 properties and proliferative capacity of dpacDP cells. Because past reports suggestedthat activation of multiple biological pathways is necessary to fully maintain DP 1 characteristics in vitro (Kishimoto et al., 2000; Shimizu and Morgan, 2004; Rendl et al., 2 2008) , DPAC could be more potentiated by the addition of activators of other signaling 3 pathways, including the Sonic hedgehog, Notch, and Endothelin pathways (Gao et al., 4 2008; Driskell et al., 2009; Hu et al., 2010) . In contrast to DP cells, fibroblasts cultured 5 in DPAC reduced ALP expression (data not shown). Thus, the conversion of other 6 dermal cells into the DP cell lineage using DPAC is not feasible. 7
A unique feature of DPAC is that it restored the DP signature gene expression and 8 functions normally reduced in conventionally cultured DP cells. The gene expression 9 recovery seems to be imperfect by, for instance, moderate upregulation of RGS2. For 10 full assessment of functional restoration, additional examinations, including the 11 evaluation of the response to androgen (Inui et al., 2002) or adenosine (Iino et al., 2007) , 12 may be performed. However, the co-culture experiment and in vivo hair induction assay 13 demonstrated that the most characteristic DP property, communication with the 14 epithelial component (Ohyama et al., 2010; Driskell et al., 2011) , was at least partly 15 restored by DPAC. These observations imply a promising strategy for the efficient 16 propagation of functional human DP cells by primary expansion under conventional 17 culture conditions, followed by functional restoration. In fact, the yield of DP cells after 18 the second passage was more than 10 times higher than that obtained through DPAC 19 expansion from primary cultures, and the time required was approximately 50% less, 20 indicating substantial advantages. The phase of isolated DPs might have affected the 21 efficiency of the restoration. In the present study, DPs were mostly microdissected from 22 full-anagen hair follicles. The role of DP in such hair follicles is to support hair shaft 23 elongation rather than hair induction (Oliver, 1967; Paus and Cotsarelis, 1999) . 24
Early-anagen DP cells may possess more potent biological capacities, including 25 resilience, than late-anagen DP cells. Although the use of such DP cells is technically 26 very challenging, it could improve the outcome of the restoration experiments. 27
In summary, we have elucidated the molecular signature of intact human anagen 28 DP cells. This guided the development of DPAC for the efficient in vitro expansion of 29 human DP cells that retain their intrinsic properties. The present study sheds new lightsupplying sufficient functional human DP cells for the development of molecules acting 1 on in vivo DPs or for regenerative medicine-based approaches to treat intractable hair 2 loss disorders. 3
Materials and Methods 1

Preparation of human dermal papillae 2
Human hair follicles were manually isolated from intact scalp skin obtained during 3 surgical removal of benign skin tumors. DPs were microdissected from the bulbar 4 portion of hair follicles under a dissection microscope as previously described 5 (Williams et al., 1994) . All experimental procedures were officially approved by the 6
Institutional Review Board of Keio University. All human donors provided written 7 informed consent in accordance with Declaration of Helsinki guidelines. 8 9
Cell culture 10
Five to six DPs were placed on the bottom of a 60-mm dish and cultured in DMEM 11 (Invitrogen, Carlsbad, CA, USA) containing penicillin and streptomycin (Roche, Basel, 12 Switzerland) and 10% FBS. For fibroblast collection, the dermis of scalp samples was 13 cut into small blocks, 2-3 mm square. The blocks were attached to the bottom of 60-mm 14 culture dishes and cultured in 10% FBS-DMEM. All cell culture was performed at 37°C 15 in 5% CO 2 . When confluent, primary cultured cells were harvested and re-seeded 16 (20,000 cells/dish). After primary culture, all cells were passaged on a weekly basis. 17
18
Dermal papilla cell aggregation 19
Cultured DP cells were incubated with 2% trypsin and then transferred into 20 low-cell-binding 96-well plates and centrifuged for several seconds to spin down the DP 21 cells, and then incubated overnight at 37°C in 5% CO 2 . 22
23
RNA isolation and real time PCR analysis 24
Total RNA was isolated from microdissected DP, DP cell aggregates and cultured DP 25 cells using an RNeasy Micro Kit (QIAGEN, Hilden, Germany). For real-time PCR 26 analyses, cDNA was synthesized using SuperScript III First-Strand Synthesis SuperMix 27 for qRT-PCR (Invitrogen, Carlsbad, CA) according to the manufacturer's protocol. 28
Real-time PCR analysis was performed using Power SYBR Green PCR Master Mix 29 (Applied Biosystems, Santa Clara, CA, USA) and a StepOne Real-Time PCR system(Applied Biosystems) and reactions were performed under the following cycling 1 conditions: 10 min at 95°C, followed by 40 cycles of 15 s at 95°C and 60 s at 60°C. The 2 primer sets used are shown in Table S5 . Target mRNA expression levels normalized to 3 the GAPDH mRNA using the ΔCt method were calculated as 2 -ΔCt . GAPDH was used 4 as the reference gene because of its similar expression in microdissected and cultured 5 DP cell populations, as shown by consistent Ct values. Three independent experiments 6 were performed in duplicate. The results are presented as the means ± standard error of 7 the means (s.e.m.). 8 9
Microarray generation 10
Isolated total RNA was amplified and biotin-labeled using a T7-primer based 11
GeneChip® Two-Cycle cDNA Synthesis Kit and an IVT Labeling Kit (Affymetrix Inc., 12 Santa Clara, CA, USA), respectively. Then, 20 μg of each labeled cRNA sample was 13 fragmented and hybridized to an Affymetrix HG-U133A 2.0 GeneChip microarray and 14 scanned using GeneChip Scanner 3000 7G (Affymetrix Inc.) according to the 15 manufacturer's protocol. 16
Microarray data analysis 18
To identify genes that are differentially expressed in intact human DP, two data 19 analyses individually consisting of two-step microarray comparisons were performed 20 using Gene Chip Operating Software ver. 1.4 (Affymetrix Inc.). For all microarrays, 21 chip files (CHIP files) were generated according to the following parameters: target 22 signal scaling, 500; Alpha1, 0.05; Alpha2, 0.065; and Tau, 0.015. Gene expression files 23 were generated based on the following parameters: Gamma1H, 0.0045; Gamma1L, 24 0.0045; Gamma2H, 0.006; Gamma2L, 0.006; and Perturbation, 1.1. Only probe sets 25 detected as being expressed (present call) in these files were analyzed. In the first 26 analysis, global gene expression for the cDP and Fibro chips was compared (n=4), and 27 probe sets whose targets were upregulated ≥2-fold in cDPs were selected. Next, the 28 expression levels of the targets for these probe sets in fDP and cDP GeneChips were 29 compared in order to identify genes whose expression was up-regulated in fDP or 30 equally expressed in fDP and cDPs. In the second analysis, two sets of GeneChips wereused to analyze total RNA samples from agDPs and cDPs in order to identify probe sets 1 whose targets were >1.5 fold upregulated by DP cell aggregation. Among the probe sets 2 upregulated in agDPs, those found to be >3-fold more highly expressed in fDP, as 3 
Bioinformatics analysis 9
The list of DP human signature genes was uploaded in DAVID, and the gene clustering 10 analysis was performed with the following settings: similarity term overlap, 3; 11 similarity threshold, 0.25; initial group membership, 2; final group membership, 2; and 12 multiple linkage threshold, 0.50. Ontological functional annotation for each gene was 13 obtained by DAVID. In addition, gene expression profiles for Approaches 1 and 2 were 14 analyzed by GeneSpring GX 11.5 software (Agilent Technologies, Santa Clara, CA, 15 USA). The MAS without baseline transformation was applied for normalization. The 16 genes were analyzed by hierarchical clustering and drawn as heat maps using the 17
GeneSpring default setting. 18 19
Development of dermal papilla activation culture condition (DPAC) 20
DP cells were cultured in 10% FBS-DMEM containing BIO (1, 2, or 4 µM; Sigma, St. 21
Louis, MO, USA) rBMP2 (100, 200, or 400 ng/ml; R&D, Minneapolis, MN, USA), or 22 bFGF (10, 20, or 40 ng/ml; PEPROTECH, Rocky Hill, NJ, USA). The growth rates of 23 DP cells under these different culture conditions were monitored every 4-5 days by 24 assessing the ratio between the size of a starting DP and an outgrowing colony. Four 25 weeks later, DP cells were collected and total RNA was extracted. Then, ALPL, NOG, 26 LEF1, and RGS2 expression levels were measured by real-time PCR as described above. 27
Subsequently, DP cells were cultured in 10% FBS-DMEM containing two activators (1 28 μM BIO and 200 ng/ml rBMP, 1 μM BIO and 20 ng/ml FGF, or 200 ng/ml rBMP and 29
Alkaline phosphatase activity detection 2
Detection of ALP activity in DP cells was performed using an ALP detection kit 3 (Chemicon Millipore, Temecula, CA, USA), according to the manufacturer's protocol. 4 5 Keratinocyte and DP co-culture 6 DP cells primarily cultured in 10% FBS-DMEM were seeded on the upper compartment 7 of 6 well Transwell culture dishes (Corning, Lowell, MA, USA) and cultured either in 8 DPAC or 10% FBS-DMEM for 1 week. At the same time, human middle follicle outer 9 root sheath keratinocytes were cultured on the collagen type I coated 6 well plates in 10 defined kerarinocyte serum free medium (Invitrogen, Carlsbad, CA, USA). At day 7, 11
Transwell dishes with DP cells were inserted into the plates with keratinocytes and 12 cultured for additional 2 days in DMEM without FBS. Then, total RNA was isolated 13 from keratinocytes for gene expression analyses. 14 15
In vivo hair induction assay 16
Freshly isolated human DP cells were conventionally cultured in 10% FBS-DMEM and 17 passaged either in DPAC or 10% FBS-DMEM. After 4 weeks of culture, aggregates of 18 DPAC-treated and control DP cells were generated as described above. Afollicular 19 footpads were surgically removed from 8-week-old ICR mice under a dissection 20 microscope and incubated with dispase I (Godo Syusei, Tokyo, Japan) (1,500 U/ml) for 21 30 min at 37°C. The epidermis was separated from the dermis and cell aggregates were 22 placed between them. The footpad skin composites were incubated on Millicell-CM 23 culture plate inserts (Millipore, Billerica MA, USA) for 2 h at 37°C in 10% 24 FBS-DMEM and grafted subcutaneously into BALB/c nu/nu nude mice. Skin samples 25 were harvested 2 weeks later for histological analysis. 26 27
Human vimentin detection 28
Frozen sections were fixed through incubation with acetone for 20 min at -20°C and 29 incubated overnight at 4°C with a monoclonal anti-human vimentin-Cy3 antibody 30 (Sigma). Cell nuclei were counterstained with 4',6-diamidino-2-phenylindole.
1
Statistical analysis 2
Statistically significant differences were identified by two-sided Student's t-test or 3
Mann-Whitney U-test, depending on the size of the sample population. A p-value of 4 less than 0.05 was considered significant. (ALP) activity (red) was maintained for more than four passages in DPAC, while it was 11 almost completely lost within two passages under control conditions. Scale bar: 100 12 μm. antibody specifically stains human DP, but not mouse DP. This antibody detected 8 ALP-positive cells surrounding a hair like structure (arrowheads), indicating that they 9 were of human origin. Scale bar: mouse DP, 10 μm; human DP, 50 μm; experimental 10 sample, 100 μm. 11 A For the genes supported by multiple probe sets, the probe set with the highest fold change between cDP and Fibro was indicated by bold letters. SDC1  TFAP2A  RGS2  LEF1  HEY1  IFI27  PIK3R3  SLCO3A1  CYP26B1  TMEM100  SPRY4  DYNC1I1  THBD  CASP1  LYN  IGF1  PTGS2  TNFAIP3  SYNM  HBEGF  LZTS1  EGR3  NTRK2  CRIP2  LXN  PLCG2  HEY2  NET1  TFAP2C  BAMBI  CSTA  MLLT11  MEF2C  LOC57228  WNT5A (aggregated DPs) MGP  GPRC5B  BMP4  CLCA2  SPON1  CCND2  CTSH  PTPRE  PEG3  VAV3  SNCAIP  BMP2  RBP1  GUCY1A3  NDP  RASL11B  ACACB  INHBB  LPL  LAM3C  HLA-DPB1  GAS7  MYLIP  ETV1  FOXO1  CSGALNACT1  RABGAP1L  JARID2  PIK3R1  SETBP1  MTUS1  PLA2G4A  RORA  GPR125  SLC7A8  MREG  BCL2  MITF  PHF15  ARHGEF3  ZMYND8  MIPEP  GMFG  TMEM100  LRP4  APOE  SPRY1  GPM6B  TRIM2  H3F3B  A2M  MMD  STON1  SEMA4C  CREM  MAF  METTL7A  SVIL  NLRP1  RGS2  SERPINI1  DIO2  AQP1  TFAP2A  MTSS1  NTRK2  APOD  SFN  RNF144A  CPE  TRPS1  EDNRA  SAT1 FGF7 GMFG IGF1  NDP WNT5A APOE INHBB  LPL MTSS1 PIK3R1 LYN  VAV3   ALX4  CREM EGR3  ETV1 FOXO1 GAS7 HEY1  HEY2 H3F3B JARID2 LEF1  LZTS1 MAF MEF2C MITF  PEG3 RORA SETBP1 SNAI1  STON1 TFAP2A TFAP2C  TNFAIP3 TRPS1  TWIST1   APOE CASP1 GMFG  NLRP1 RABGAP1L  RGS2 
Journal of Cell Science Accepted manuscript
